Big Gain For Marker Therapeutics, Inc.
Mon, Dec 11, 2023 at 07:11 PM
Marker Therapeutics, Inc. (MRKR:NASDAQ) rocketted at $4.71, representing a gain of 42.7%. On Mon, Dec 11, 2023, MRKR:NASDAQ touched a New 2-Week High of $4.71. From Mon, Nov 27, 2023, the stock recorded 60.00% Up Days and 72.73% Green Days
About Marker Therapeutics, Inc. (MRKR:NASDAQ)
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 100%
- JetAI Inc Com (JTAI:NASDAQ), 81.93%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 71.44%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 45.05%
- SaverOne 2014 Ltd. (SVRE:NASDAQ), 45%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 42.73%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 40.13%
- IN8bio Inc. (INAB:NASDAQ), 29.29%
- Innoviz Technologies Ltd. (INVZ:NASDAQ), 27.78%
- Surf Air Mobility Inc. (SRFM:NYSE), 27.13%